“Double dose” HLA-DRB1*04 SE genotypes were found to modestly increase the risk of vasculitis (OR 2.44) and the overall risk of extra-articular RA (OR 1.79) [130]. This evidence concerns the gene HLA-DRB1 and vasculitis.